Enterprise AI Analysis: Single-cell spatial proteomics maps human liver zonation patterns and their vulnerability to disruption in tissue architecture
Unveiling Liver Zonation at Single-Cell Resolution
Our innovative Deep Visual Proteomics approach delivers the first comprehensive spatial map of the human hepatic proteome, identifying critical metabolic gradients and revealing how tissue architecture disruption impacts liver function. This foundational work sets a new standard for spatial proteomics in complex biological systems.
Revolutionizing Liver Disease Research with Spatial Proteomics
The application of single-cell Deep Visual Proteomics (scDVP) to human liver tissue marks a significant leap in understanding organ function and disease progression. By mapping protein distribution patterns with unprecedented resolution, this research unlocks new avenues for diagnostics and targeted therapies.
0
Proteins Identified per Hepatocyte
0
Proteins Showing Zonation
0
Individuals Analyzed
0
Samples Processed per Day
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
This section details the technological advancements in single-cell Deep Visual Proteomics (scDVP) that enable high-resolution spatial proteome analysis. We describe our novel automated cell selection strategy, continuous protein gradient mapping framework, and ultra-high-sensitivity mass spectrometry approach, which collectively enhance throughput and data fidelity for large-scale clinical cohorts. These innovations are critical for bridging the gap between molecular profiles and spatial tissue context.
Here, we present the comprehensive spatial map of the human hepatic proteome, analyzing hundreds of isolated hepatocytes from 18 individuals. This analysis identified over 2,500 proteins per cell, with about half exhibiting zonated expression. We compare these findings with mouse models, revealing conserved metabolic functions and human-specific features of liver zonation, such as periportal enrichment of ribosomal proteins. This map serves as an open-access resource for understanding liver organization.
We investigate how disrupted liver architecture, particularly in desmoplastic tissue associated with metastatic liver disease, affects protein zonation patterns. Our findings reveal a widespread loss of protein zonation in affected samples, with pericentral proteins demonstrating particular vulnerability to spatial disorganization. This highlights the critical link between tissue integrity and functional metabolic compartmentalization, offering insights into disease progression and potential therapeutic targets.
2539
Median Proteins Per Cell
Enterprise Process Flow
High-Resolution Microscopy
→
AI-Guided Cell Segmentation
→
Automated Cell Selection & Trajectory Mapping
→
Laser Microdissection
→
Ultra-High-Sensitivity MS Analysis
→
Continuous Protein Gradient Mapping
→
Spatial Proteome Map Generation
| Feature | scDVP Approach | Traditional Bulk Proteomics |
|---|---|---|
| Resolution |
|
|
| Throughput |
|
|
| Data Output |
|
|
| Disease Insights |
|
|
Case Study: Uncovering Ribosomal Zonation
A novel finding from our human liver spatial proteome map is the distinct periportal enrichment of ribosomal proteins, a pattern not observed in mouse models. This suggests a species-specific variation in protein synthesis capacity across the liver lobule, potentially linked to higher protein synthesis demands in oxygen-rich periportal regions for plasma protein production.
Quantify the Impact: Your Enterprise AI ROI
Estimate the potential return on investment for implementing our advanced AI-driven proteomics solutions in your organization. Our calculator considers key operational factors to provide a tailored projection of efficiency gains and cost savings.
Seamless Integration: Our Implementation Roadmap
Our phased approach ensures a smooth transition and rapid value realization. From initial assessment to full operationalization, we partner with you every step of the way.
Phase 1: Discovery & Strategy
Collaborate to understand your unique challenges and define clear objectives for AI integration. This includes data assessment, infrastructure readiness, and ROI projection tailored to your enterprise.
Phase 2: Solution Design & Customization
Based on the strategic blueprint, we design and customize the scDVP solution, including specific assay development, AI model training, and integration with existing lab information systems (LIMS) or data platforms.
Phase 3: Pilot & Validation
Deploy the solution in a controlled pilot environment. We perform rigorous testing and validation, ensuring data quality, accuracy, and reproducibility, and gather initial insights to fine-tune the system.
Phase 4: Full-Scale Deployment & Training
Roll out the scDVP platform across your organization. Comprehensive training is provided for your team, ensuring confident and efficient use of the new capabilities.
Phase 5: Optimization & Ongoing Support
Continuous monitoring and optimization of the AI models and workflows to maximize performance and adapt to evolving research needs. We provide dedicated support and regular updates.
Ready to Transform Your Research?
Unlock the full potential of single-cell spatial proteomics for your enterprise. Our team is ready to discuss how Deep Visual Proteomics can accelerate your discoveries and drive innovation.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat